Venetoclax Synergizes With Radiotherapy for Treatment of B-Cell Lymphomas

Cancer Research - United States
doi 10.1158/0008-5472.can-17-0082
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Clinical Outcomes From Venetoclax Based Therapy in Patients With Relapsed/Refractory B-Cell Lymphomas

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Emerging Treatment Options for B-Cell Lymphomas

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2015English

Early B-Cell-Specific Inactivation of ATM Synergizes With Ectopic CyclinD1 Expression to Promote Pre-Germinal Center B-Cell Lymphomas in Mice

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2015English

Copanlisib Synergies With Conventional and Targeted Agents Including Venetoclax in Preclinical Models of B- And T-Cell Lymphomas

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Pretargeted Radioimmunotherapy for B-Cell Lymphomas

Clinical Cancer Research
Cancer ResearchOncology
2007English

Liposomes Modified by Carbohydrate Ligands Can Target B Cells for the Treatment of B-Cell Lymphomas

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2010English

Ruxolitinib Treatment and Risk of B‐cell Lymphomas in Myeloproliferative Neoplasms

American Journal of Hematology
Hematology
2019English

Double-Hit B-Cell Lymphomas

Blood
BiochemistryImmunologyCell BiologyHematology
2011English

Treatment of High Risk Aggressive B Cell Lymphomas With Da Epoch R- The Austrian Experience

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy